Related Experiment Video
Updated: Jul 13, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients.
Ronda Lun1,2,3, Joshua O Cerasuolo4,5, Marc Carrier6,7
1Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, ON, Canada (R.L., M.S., D.D.).
Individuals with a history of ischemic stroke (IS) face a nearly threefold higher risk of experiencing another stroke after a new cancer diagnosis. This risk is highest when the prior stroke occurred within one year before the cancer diagnosis.
Area of Science:
- Oncology
- Neurology
- Cardiovascular Medicine
Background:
- Previous ischemic stroke (IS) is a known risk factor for subsequent IS in the general population.
- The relationship between prior IS and future IS risk in cancer patients remains unclear.
Purpose of the Study:
- To examine the association between a history of ischemic stroke (IS) and the risk of subsequent IS in individuals newly diagnosed with cancer.
Main Methods:
- Retrospective, population-based, matched cohort study in Ontario, Canada (2010-2020).
- Matched 13,070 cancer patients with prior IS to 52,455 cancer patients without prior IS.
- Used cumulative incidence functions and subdistribution adjusted hazard ratios (aHRs), treating death as a competing event.
Main Results:
- Individuals with prior IS had a significantly increased risk of IS after cancer diagnosis (aHR, 2.68).
- The highest stroke risk was observed in gynecologic (aHR, 3.84) and lung cancer (aHR, 3.18) subgroups.
- Stroke risk was inversely correlated with lag time; IS within 1 year before cancer diagnosis showed the highest risk (aHR, 3.68).
Conclusions:
- A history of ischemic stroke (IS) nearly triples the risk of experiencing a subsequent stroke after a new cancer diagnosis.
- The risk is particularly elevated if the prediagnosis stroke occurred within the year preceding the cancer diagnosis.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Psychoneuroimmunology: Diabetes and Cancer
Atherosclerosis IV: Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

